ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Two years after implant, patients who use Abbott Laboratories' implantable spinal cord stimulators for chronic pain continue to prefer the company's proprietary stimulation pattern over traditional ...
Spinal cord stimulation (SCS) therapies for chronic back and/or leg pain is superior to conventional medical management (CMM) for reduced pain intensity and functional disability, new research ...
Neurostimulation continues to be an area that companies are exploring to deliver improved therapy for a variety of conditions. On Tuesday, St. Jude Medical announced that launch of a new U.S. study to ...
A guitarist in a death metal band was one of several people who found that personalized deep brain stimulation eased their pain and helped them reduce pain medication. A guitarist in a death metal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback